Drug-coated balloons are widely used treatment and novel medical devices used in the treatment of percutaneous coronary intervention (PCI). These medical devices are designed to dilate the stenotic coronary and peripheral artery while delivering drug to suppress neointimal hyperplasia. Drug-coated balloons (DCB) are also referred to as drug-eluting balloons. They are semi-compliant angioplasty balloons covered with anti-proliferative medicine, which is delivered into the vessel during inflammation of the balloon.

1 Executive 
2 Market Landscape 

3 Market Sizing 

4 Historic Market Size 

5 Five Forces Analysis

6 Market Segmentation by Distribution Channel

7 Market Segmentation by Technology

8 Customer Landscape 

9 Geographic Landscape